These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline. Feller-Kopman DJ; Reddy CB; DeCamp MM; Diekemper RL; Gould MK; Henry T; Iyer NP; Lee YCG; Lewis SZ; Maskell NA; Rahman NM; Sterman DH; Wahidi MM; Balekian AA Am J Respir Crit Care Med; 2018 Oct; 198(7):839-849. PubMed ID: 30272503 [TBL] [Abstract][Full Text] [Related]
4. Recent developments in pleurodesis for malignant pleural disease. Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207 [TBL] [Abstract][Full Text] [Related]
5. [Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)]. Chinese Thoracic Society, Chinese Medical Association Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1189-1203. PubMed ID: 38044047 [TBL] [Abstract][Full Text] [Related]
6. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341 [TBL] [Abstract][Full Text] [Related]
7. Update on the diagnosis and management of malignant pleural effusions. Bashour SI; Mankidy BJ; Lazarus DR Respir Med; 2022 May; 196():106802. PubMed ID: 35287006 [TBL] [Abstract][Full Text] [Related]
8. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management. Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020 [TBL] [Abstract][Full Text] [Related]
9. Interventional therapies for malignant pleural effusions: the present and the future. Thomas R; Francis R; Davies HE; Lee YC Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955 [TBL] [Abstract][Full Text] [Related]
10. Malignant pleural effusion in the palliative care setting. Arber A; Clackson C; Dargan S Int J Palliat Nurs; 2013 Jul; 19(7):320, 322-5. PubMed ID: 24273808 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655 [TBL] [Abstract][Full Text] [Related]
12. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235 [TBL] [Abstract][Full Text] [Related]
14. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters. Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209 [TBL] [Abstract][Full Text] [Related]
15. Malignant Pleural Effusion: Still a Long Way to Go. Meriggi F Rev Recent Clin Trials; 2019; 14(1):24-30. PubMed ID: 30514193 [TBL] [Abstract][Full Text] [Related]
16. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Yeung M; Loh EW; Tiong TY; Tam KW Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317 [TBL] [Abstract][Full Text] [Related]
17. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis. Srour N; Amjadi K; Forster A; Aaron S Can Respir J; 2013; 20(2):106-10. PubMed ID: 23616967 [TBL] [Abstract][Full Text] [Related]
18. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis. Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486 [TBL] [Abstract][Full Text] [Related]
19. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Stefani A; Natali P; Casali C; Morandi U Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008 [TBL] [Abstract][Full Text] [Related]
20. Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions. MacEachern P; Tremblay A Respirology; 2011 Jul; 16(5):747-54. PubMed ID: 21545373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]